97. Ulcerative colitis Clinical trials / Disease details

Clinical trials : 2,630 / Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05117749 (ClinicalTrials.gov)	May 2023	21/10/2021	Saffron and Ulcerative Colitis	The Effect of Saffron in Patients With Ulcerative Colitis: A Randomized Double-blind Clinical Trial	Ulcerative Colitis	Drug: Saffron 100;Drug: Saffron 50;Drug: Placebo	Shiraz University of Medical Sciences	NULL	Not yet recruiting	18 Years	80 Years	All	60	Phase 2	NULL
2	NCT05715099 (ClinicalTrials.gov)	March 30, 2023	19/1/2023	Saffron as Anti Inflammatory In Patients With Inflammatory Bowel Disease	Efficacy of Nutritional Saffron Supplement as an Anti-inflammatory Agent in Egyptian Patients With Inflammatory Bowel Disease	Ulcerative Colitis	Drug: Saffron;Drug: Placebo	Minia University	NULL	Not yet recruiting	18 Years	60 Years	All	90	Phase 4	Egypt
3	NCT04749576 (ClinicalTrials.gov)	December 15, 2020	9/12/2020	Saffron as Anti Inflammatory Agent In Patients With Inflammatory Bowel Disease	Efficacy of Nutritional Saffron Supplement As An Anti Inflammatory Agent In Patients With Inflammatory Bowel Disease	Ulcerative Colitis	Dietary Supplement: saffron supplement for IBD	Howard University	NULL	Recruiting	18 Years	80 Years	All	100	N/A	United States